Dr. Qudsia Khan, chief medical officer at Northwest Integrated Health in Tacoma, Wash., will discuss the results of a recently published study in the Journal of Substance Abuse Treatment, which demonstrated that addiction treatment patients using Cordant’s managed pharmacy program had more successful outcomes.
Christopher P. Harlow, PharmD, BCGP, director of pharmacy services at Cordant Health Solutions, will discuss the positive impact Cordant's program has on reducing stigma and increasing access to medications like buprenorphine for the treatment of opioid use disorder.
Cordant’s managed MAT pharmacy program has been shown to have a positive impact on patient outcomes, including:
52% higher retention in treatment
46% fewer opiate-positive lab tests
41% fewer drug-related emergency department visits
Join this webinar to see how Cordant's managed pharmacy program could have an impact on your patients' recovery.
Registration is required to attend.